Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schechter

Showing results (341-350 of 354) with videos related to

Pageof 36
Sort By:
Cell|March 1, 2024
A cryptic plasmid is among the most numerous genetic elements in the human gutEmily C Fogarty, Matthew S Schechter, Karen Lolans, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 30, 2023
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical studyS M Rowe, J B Zuckerman, D Dorgan, et al.
Annals of the American Thoracic Society|September 8, 2025
Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies After Rapid Adoption: A Dual-Approach StudyPedro Miranda Afonso, Grace C Zhou, Weiji Su, et al.
Nature Microbiology|May 16, 2025
Author Correction: Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respirationAlexander S Little, Isaac T Younker, Matthew S Schechter, et al.
Nature Microbiology|January 4, 2024
Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respirationAlexander S Little, Isaac T Younker, Matthew S Schechter, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2015
Official American Thoracic Society technical standards: flexible airway endoscopy in childrenAlbert Faro, Robert E Wood, Michael S Schechter, et al.
Annals of the American Thoracic Society|March 8, 2023
Lung Function Decline in Cystic Fibrosis: Impact of Data Availability and Modeling Strategies on Clinical InterpretationsRhonda Szczesniak, Eleni-Rosalina Andrinopoulou, Weiji Su, et al.
The Journal of Urology|August 1, 2016
Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina BifidaJonathan C Routh, Earl Y Cheng, J Christopher Austin, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 24, 2024
Standards for the care of people with cystic fibrosis (CF); Planning for a longer lifeAndrea Gramegna, Charlotte Addy, Lorna Allen, et al.
Pageof 36

Showing results (341-350 of 354) with videos related to

Sort By:
Pageof 36
Cell|March 1, 2024
A cryptic plasmid is among the most numerous genetic elements in the human gutEmily C Fogarty, Matthew S Schechter, Karen Lolans, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 30, 2023
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical studyS M Rowe, J B Zuckerman, D Dorgan, et al.
Annals of the American Thoracic Society|September 8, 2025
Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies After Rapid Adoption: A Dual-Approach StudyPedro Miranda Afonso, Grace C Zhou, Weiji Su, et al.
Nature Microbiology|May 16, 2025
Author Correction: Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respirationAlexander S Little, Isaac T Younker, Matthew S Schechter, et al.
Nature Microbiology|January 4, 2024
Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respirationAlexander S Little, Isaac T Younker, Matthew S Schechter, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2015
Official American Thoracic Society technical standards: flexible airway endoscopy in childrenAlbert Faro, Robert E Wood, Michael S Schechter, et al.
Annals of the American Thoracic Society|March 8, 2023
Lung Function Decline in Cystic Fibrosis: Impact of Data Availability and Modeling Strategies on Clinical InterpretationsRhonda Szczesniak, Eleni-Rosalina Andrinopoulou, Weiji Su, et al.
The Journal of Urology|August 1, 2016
Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina BifidaJonathan C Routh, Earl Y Cheng, J Christopher Austin, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 24, 2024
Standards for the care of people with cystic fibrosis (CF); Planning for a longer lifeAndrea Gramegna, Charlotte Addy, Lorna Allen, et al.
Pageof 36